Pfizer Inc. today announced positive topline results from the progression-free survival (PFS) analysis of the Phase 3 BREAKWATER study of BRAFTOVI® (encorafenib) in combination with cetuximab ...

Because H5N1 is a form of influenza A ... "Having learned from the COVID pandemic, we want to be prepared," Chopra said. "We are developing our own ... in-house test. ... If we have evidence ...

Enhancing pharmacovigilance ... form that I can fill out quickly on my phone or computer would make a big difference.” (Pharmacist: 11). “Digitalizing the reporting process would reduce the burden and ...

Spontaneous reporting continues to play an important role in pharmacovigilance and the value of astute clinical observation and well-documented reports of suspicions of a causal link cannot be ...

SARS-CoV-2 infection was associated with more rapid coronary plaque progression and significantly increased risk for adverse ...

So when does 9-1-1 return with new episodes? We’ve got answers. 9-1-1‘s midseason finale, which aired back on November 21, 2024, was fairly tame compared to fans’ expectations. But the ...

The CDC ACIP recommends 2 doses of the 2024-2025 COVID-19 vaccine for those age 65+ years and 2 or more doses for immunocompromised individuals.

A study done by the University of Minnesota (U of M) found that early adult deaths are on the rise in the U.S., with COVID-19 ...

Paxlovid may offer marginal benefits for low-risk children with COVID-19; however, among high-risk children with COVID-19, Paxlovid is a safe oral option.

People who have had multiple bouts of COVID-19 or had it severely, and those who were unvaccinated when first infected, had an increased risk of developing long COVID, according to a new study by ...